Maintaining a good delivery record: Established EHS (Environmental Occupational Health and Safety) management system, quality management system and intellectual property, commercial secret protection system, and through continuous optimization and improvement of production processes, control or reduce waste water and waste gas from the source. Emissions, the implementation of green production, the accumulation of compliance and good delivery records, has passed the audit of important downstream customers. Route design and process development Process Optimization Intermediate production
Advantage two
The company focuses on the small molecule new drug process research and development and production market segments in the field of small molecule chemical drugs. It has the advantages of reasonable team structure, flexibility and strong cohesion, high execution efficiency, and low company operating costs, and has accumulated an efficient and good delivery record.
Intermediates Development & Manufacturing
Service Items
Service Content
Team advantage: Has been committed to the process development and industrialization process improvement research of pharmaceutical intermediates and APIs, cultivated close and effective process development-optimization-production teamwork, mastered and successfully applied a wealth of chemical synthesis technology. With years of technology, experience accumulation, professional process research, high-level quality management and project management system of the R&D team, we can effectively carry out process improvement, quality analysis and research, and ensure the compliance and scale of production to ensure APIs and intermediates. production and supply.
Advantage one
优势三
Equipment and venue: With a professional analysis team, a complete analysis service platform has been established, equipped with a series of advanced analysis and testing equipment such as HPLC, GC, LC-MS, etc. The company will continue to increase the construction of the R&D platform and purchase new equipment such as preparative liquid phase, CAD detector and the latest chromatograph. The construction of the industrialization base is under preparation and is expected to start in 2023. At present, it has established strategic cooperation with pharmaceutical companies with standardized production platforms (Zhongshan base and Guangxi base, including API/preparation GMP workshops) to form a mutually beneficial and complementary model of R&D and production, so as to better promote innovation and the transformation of scientific and technological achievements.
